More on MNKD
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.55 |
|
|||
| Open | $3.61 | ||||
| 52 Wk High | $2.51 | ||||
| 52 Wk Low | $0.41 | ||||
| Day High | $3.68 | ||||
| Day Low | $3.53 | ||||
| P/E | N/A | ||||
| EPS | $-0.64 | ||||
| Volume | 2,733,344 | ||||
- Form 4 MANNKIND CORP For: Sep 10 Filed by: Binder Steven B.
- MannKind (MNKD) Reiterated at Overweight by Cantor Fitzgerald on Positive MNKD-201 Ph1 Data
- MannKind (MNKD) Reiterated at Overweight by Cantor Fitzgerald on Positive MNKD-201 Ph1 Data
- Form 144 MANNKIND CORP Filed by: Binder Steven B.
- MannKind and Rose Pharma agree to develop inhaled GLP-1 therapy
- MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management
- MannKind to Present at Upcoming Investor Conferences
- Form 8-K MANNKIND CORP For: Aug 21
- Form 424B7 MANNKIND CORP
- Form SCHEDULE 13G MANNKIND CORP Filed by: Rubric Capital Management LP
Entities mentioned with MNKD
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- Pre Market Movers | View Related Stories »
- H.C. Wainwright | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
